Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Leucocitoaferesi
Connect with this vendor - Learn about this product

Leucocitoaferesi

Proportional adsorption technology based on  MediSulfone®, the Leukocyte Adsorber LA25 is used for the treatment of autoimmune diseases for an effective and selective removal of leukocytes from the blood by the patient. Crohn's disease and ulcerative rectocolitis are a good example of the diseases that can benefit from these therapies.